Price T Rowe Associates Inc Cyma Bay Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$12.63 - $24.47 $32.4 Million - $62.7 Million
2,561,460 Added 134.55%
4,465,161 $105 Million
Q3 2023

Nov 14, 2023
BUY
$10.86 - $17.62 $19.6 Million - $31.9 Million
1,809,280 Added 1916.18%
1,903,701 $28.4 Million
Q2 2023

Aug 14, 2023
BUY
$7.47 - $10.95 $162,920 - $238,819
21,810 Added 30.04%
94,421 $1.03 Million
Q1 2023

May 15, 2023
SELL
$5.88 - $9.59 $334,019 - $544,769
-56,806 Reduced 43.89%
72,611 $634,000
Q4 2022

Feb 14, 2023
SELL
$3.22 - $6.27 $147,099 - $286,432
-45,683 Reduced 26.09%
129,417 $811,000
Q3 2022

Nov 14, 2022
BUY
$2.77 - $4.25 $146,533 - $224,825
52,900 Added 43.29%
175,100 $613,000
Q2 2022

Aug 15, 2022
BUY
$1.72 - $3.39 $20,772 - $40,941
12,077 Added 10.97%
122,200 $360,000
Q1 2022

May 16, 2022
BUY
$2.77 - $3.64 $37,317 - $49,038
13,472 Added 13.94%
110,123 $342,000
Q4 2021

Feb 14, 2022
SELL
$3.23 - $4.6 $132,181 - $188,245
-40,923 Reduced 29.75%
96,651 $327,000
Q2 2021

Aug 16, 2021
BUY
$3.94 - $4.92 $268,861 - $335,735
68,239 Added 98.42%
137,574 $600,000
Q1 2021

May 17, 2021
BUY
$4.23 - $6.55 $90,424 - $140,019
21,377 Added 44.57%
69,335 $315,000
Q4 2020

Feb 16, 2021
BUY
$5.73 - $9.03 $274,799 - $433,060
47,958 New
47,958 $275,000

Others Institutions Holding CBAY

# of Institutions
6
Shares Held
1.82M
Call Options Held
0
Put Options Held
0
View Full List

About CymaBay Therapeutics, Inc.

CBAY Quotes by TradingView
  • Ticker CBAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,677,904
  • Description
  • CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...
More about CBAY
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email